Latest S-1 registration statements

TCFIII Spaceco Holdings LLC, soon to be Karman Holdings Inc., has filed an S-1 registration statement for an initial public offering of its common stock, seeking a listing on the NYSE under the ticker 'KRMN'.

Phio Pharmaceuticals is registering for resale up to 5.9 million shares of common stock, primarily related to warrants issued in recent private placements.

Theriva Biologics is planning a best-efforts public offering of up to 6,756,756 shares of common stock and accompanying warrants, or pre-funded warrants, to raise capital for working capital and general corporate purposes.

LogicMark, Inc. plans to offer units consisting of common stock and warrants to fuel sales, marketing, and working capital.

FG Merger II Corp updates its corporate structure with amended articles of incorporation, focusing on potential mergers within the North American financial services sector.

Biofrontera Inc. has filed a registration statement for the resale of up to 5.7 million shares of common stock by selling stockholders, primarily stemming from the conversion of senior secured convertible notes.

Scorpius Holdings is conducting a public offering of up to 26,315,789 shares of common stock and pre-funded warrants to raise capital for working capital and general corporate purposes.

Salarius Pharmaceuticals will merge with Decoy Therapeutics in a stock-for-stock transaction, shifting focus to peptide conjugate therapeutics.

Sunrise Realty Trust, Inc. announces a public offering of 5.5 million shares of its common stock to fund loan commitments and support its growth strategy in the Southern U.S. commercial real estate market.

Infinity Natural Resources, Inc. has filed an amendment to its Form S-1 registration statement for its initial public offering of Class A common stock.

Smithfield Foods files amended and restated bylaws outlining procedures for shareholder meetings, director nominations, and other corporate governance matters in preparation for its upcoming IPO.

CERo Therapeutics is offering up to 4 million shares of common stock, pre-funded warrants, and common warrants in a new offering.

Blaize Holdings, Inc. has filed a registration statement for the resale of 89,405,192 shares of common stock and 898,250 warrants, alongside the issuance of 29,648,250 shares upon warrant exercise, marking a significant financial restructuring following its recent merger.

Bio-Path Holdings is seeking to raise capital through a public offering of common stock and warrants, while continuing to advance its clinical-stage oncology and obesity-focused drug candidates.

ReShape Lifesciences Inc. has filed a registration statement for a potential offering of up to $3.5 million in common stock, as the company navigates a proposed merger and asset sale.

Archimedes Tech SPAC Partners II Co. has filed an amended S-1 registration statement with the SEC for a $200 million initial public offering, aiming to merge with a technology business.

Bitmine Immersion Technologies formalizes its commitment to ethical business conduct with a newly filed Code of Ethics, applicable to all directors, officers, and employees.

Iron Horse Acquisitions Corp. II, a new blank check company led by experienced SPAC executives, is launching a $250 million initial public offering to pursue business combinations primarily within the media and entertainment industry, with a focus on content studios, film production, family entertainment, animation, music, gaming, e-sports, and talent-facing brands.

Kiromic BioPharma is seeking to raise capital through a public offering of units, each consisting of one share of common stock and a warrant, to further its development of allogeneic Gamma Delta T-cell therapies for solid tumors.

iQSTEL Inc. has filed a registration statement for the potential resale of up to 15,000,000 shares of common stock by a selling shareholder, while also acknowledging substantial doubt about its ability to continue as a going concern.

Expion360 Inc. has filed a registration statement for the resale of up to 1,048,386 shares of common stock issuable upon the exercise of warrants.

Sionna Therapeutics, a clinical-stage biopharmaceutical company, has filed an S-1 registration statement for an initial public offering to fund the development of novel medicines for cystic fibrosis.

Virpax Pharmaceuticals aims to raise capital through a public offering of common stock and pre-funded warrants to fund clinical trials and for general corporate purposes.

Direct Digital Holdings has filed a registration statement for the resale of 8.5 million shares of its Class A common stock by New Circle Principal Investments LLC.

SailPoint, backed by Thoma Bravo, files for an IPO aiming to enhance financial flexibility and market presence while Thoma Bravo is expected to maintain significant control.

N2OFF, Inc. has filed a registration statement for the resale of up to 53,125,000 shares of common stock by selling stockholders, following a recent private placement.

Odyssey Therapeutics, a clinical-stage biopharmaceutical company, has filed an S-1 registration statement for an initial public offering, seeking to advance its pipeline of immunomodulatory therapies.

NewHold Investment Corp III, a blank check company, aims to raise $175 million through an IPO to pursue a business combination in the industrial technology sector.

Damon Inc. has filed a registration statement for the resale of up to 18.5 million common shares by existing securityholders, including Streeterville Capital and Maxim Partners.

AEye Inc. has filed a registration statement for the resale of up to 5,353,710 shares of its common stock by certain selling stockholders.